We are very excited and proud to announce that in July 2010 the Chinese Journal of Lung Cancer(CJLC) has been selected by the National Library of Medicine (NLM) to be indexed in Medline/Index Medicus, the world's most important biomedical bibliographical database. NLM uses an advisory committee, the Literature Selection Technical Review Committee, composed of authorities knowledgeable in the field of biomedicine, such as physicians, researchers, educators, editors, health science librarians, and historians, to review and recommend the journal titles NLM should index. Only 15-20% of medical journals are selected at each session for inclusion in Medline, and even fewer journals in Chinese have been selected for indexing so far. The Committee recently completed a review of journals for possible inclusion in the National Library of Medicine's database systems and decided to select the "Chinese Journal of Lung Cancer" for indexing and inclusion in Index Medicus and Medline. In China, Chinese Journal of Lung Cancer is the 3^rd journal indexed by Medline/Pubmed, following Chinese Journal of Cancer(Guangzhou) and Chinese Journal of Oncology(Beijing). On behalf of the editorial board, I would like to express our sincere appreciation to you for the vigorous support. 

2010年6月，经美国National Institutes of Health机构咨询委员会The Literature Selection Technical Review Committee评定，中国抗癌协会、中国防痨协会和天津医科大学总医院主办的《中国肺癌杂志》，正式被MEDLINE/PUBMED/Index Medicus收录，成为继《癌症》、《中华肿瘤杂志》后我国被MEDLINE收录的第三本肿瘤学专业期刊，也是我国唯一一本被收录的胸心外科学专业期刊。